sceptrin: structure given in first source; isolated from marine sponges of the genus Agelas; RN from CHEMLINE
ID Source | ID |
---|---|
PubMed CID | 157394 |
CHEMBL ID | 307456 |
CHEBI ID | 80954 |
MeSH ID | M0207439 |
Synonym |
---|
CHEMBL307456 |
chebi:80954 , |
sceptrin |
C17166 |
79638-16-7 |
DTXSID00276460 |
Q15424768 |
Class | Description |
---|---|
pyrroles | An azole that includes only one N atom and no other heteroatom as a part of the aromatic skeleton. |
secondary carboxamide | A carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1). |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID379936 | Antiviral activity against HIV1 in human PBM cells | 2006 | Journal of natural products, Dec, Volume: 69, Issue:12 | Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. |
AID379938 | Antileishmanial activity against Leishmania donovani | 2006 | Journal of natural products, Dec, Volume: 69, Issue:12 | Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. |
AID477229 | Cytotoxicity against human KB cells at 30 uM | 2010 | Journal of natural products, Apr-23, Volume: 73, Issue:4 | Agelastatin E, agelastatin F, and benzosceptrin C from the marine sponge Agelas dendromorpha. |
AID468185 | Displacement of [3H]BQ-123 from human ETA receptor in human SK-N-MC cells at 100 ug/ml after 60 mins by scintillation counting | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12 | 5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor. |
AID379927 | Antifungal activity against Cryptococcus neoformans | 2006 | Journal of natural products, Dec, Volume: 69, Issue:12 | Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. |
AID468188 | Displacement of [3H]NPY from neuropeptide Y1 receptor in human SK-N-MC cells at 10 ug/ml after 60 mins by scintillation counting | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12 | 5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor. |
AID468187 | Displacement of [3H]NPY from neuropeptide Y1 receptor in human SK-N-MC cells at 100 ug/ml after 60 mins by scintillation counting | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12 | 5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor. |
AID379937 | Antimycobacterial activity against Mycobacterium tuberculosis at 128 ug/mL | 2006 | Journal of natural products, Dec, Volume: 69, Issue:12 | Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. |
AID468186 | Displacement of [3H]BQ-123 from human ETA receptor in human SK-N-MC cells at 10 ug/ml after 60 mins by scintillation counting | 2009 | Journal of natural products, Dec, Volume: 72, Issue:12 | 5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 11 (55.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (95.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |